Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adams, J.M., and Cory, S., 1998, The bcl-2 protein family: arbiters of cell survival, Science 281:1322–1326.
Anderson, S.C., Johnson, D.E., Harris, M.P., Engler, H., Hancock, W, Huang, W.M., Wills, K.N., Gregory, R.J., Sutjipto, S., Wen, S.F., Lofgren, S., Shepard, H.M., and Maneval, D.C., 1998, p53 gene therapy in a rat model of hepatocellular carcinoma: intra-arterial delivery of a recombinant adenovirus, Clin. Cancer Res. 4:1649–1659.
Antonsson, B., Conti, F., Ciavatta, A., Montessuit, S., Lewis, S., Martinou, I., Bernasconi, L., Bernard, A., Mermod, J.J., Mazzei, G., Maundrell, K., Gambale, F., Sadoul, R., and Martinou, J.C., 1997, Inhibition of Bax channel-forming activity by Bcl-2, Science 277:370–372.
Bischoff, J.R., Kirn, D.H., Williams, A., Heise, C, Horn, S., Muna, M., Ng, L., Nye, J.A., Sampson-Johannes, A., Fattaey, A., and McCormick, F., 1996, An adenovirus mutant that replicates selectively in p53-deficient human tumor cells. Science 274:373–376.
Bishop, J.M., 1991, Molecular themes in oncogenesis, Cell 64:235–248.
Borrelli, E., Heyman, R., His, M., and Evans, R.M., 1988, Targeting of an inducible toxic phenotype in animal cells. Proc. Natl. Acad. Sci. USA 85:7572–7576.
Chellappan, S.P., Giordano, A., and Fisher, P.B., 1998, Role of cyclin-dependent kinases and their inhibitors in cellular differentiation and development, Curr. Topics Microbiol. Immunol. 227:57–103.
Chen, Q.R., and Mixson, J.A., 1998, Systemic gene therapy with p53 inhibits breast cancer: recent advances and therapeutic implications, Frontiers Bioscience 3:D997–D1004.
Clark, W, 1991, Tumor progression and the nature of cancer, Br. J. Cancer 64:631–644.
Crystal, R.G., 1995, Transfer of genes to humans: early lessons and obstacles to success, Science 270:404–410.
Culver, K.W., Ran, Z., Wallbridge, S., Ishii, H., Oldfield, E.H., and Blaese, R.M., 1992. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors, Science 256:1550–1552.
Dematteo, R.P., McClane, S.J., Fisher, K., Yeh, H., Chu, G., Burke, C., and Raper, S.E., 1997, Engineering tissue-specific expression of a recombinant adenovirus: selective transgene transcription in the pancreas using the amylase gene, J. Surgical Res. 72:155–161.
DeYoung, K.L., Ray, M.E., Su, Y.A., Anzick, S.L., Johnstone, R.W., Trapani, J.A., Meltzer, P.S., and Trent, J.M., 1997, Cloning a novel member of the human interferon-inducible gene family associated with control of tumorigenicity in a model of human melanoma, Oncogene 15:453–457.
Du, Y.X., Zhou, B.S., and Wu, J.M., 1998, Lifestyle factors and human lung cancer: an overview of recent advances (review), Intl. J. Oncology 13:471–479.
El-Deiry, W.S., Tokino, T., Velculescu, V.E., Levy, D.B., Parsons, R., Trent, J.M., Lin, D., Mercer, W.E., Kinzler, K.W., and Vogelstein, B., 1993, WAF1, a potential mediator of p53 tumor suppression, Cell 75:817–825.
Fisher, P.B., 1984, Enhancement of viral transformation and expression of the transformed phenotype by tumor promoters, in: Tumor Promotion and Carcinogenesis In Vitro, Mechanisms of Tumor Promotion, (T.J. Slaga, ed.), pp. 57–123, CRC Press, Boca Raton, Florida.
Fisher, P.B., Prignoli, D.R., Hermo, H., Jr., Weinstein, I.B., and Pestka, S., 1985, Effects of combined treatment with interferon and mezerein on melanogenesis and growth in human melanoma cells, J. Interferon Res. 5:11–22.
Gervais, J.L., Seth, P., and Zhang, H., 1998, Cleavage of CDK inhibitor p21(Cip1/Waf1) by caspases is an early event during DNA damage-induced apoptosis, J. Biol. Chem. 273:19207–19212.
Gotoh, A., Kamidono, S., and Chung, L.W., 1997, Clinical application for gene therapy in prostate cancer, Ada Urologica Japonica 43:829–833.
Green, D.R., and Reed, J.C., 1998, Mitochondria and apoptosis, Science 281:1309–1312.
Gross, A., Jockel, J., Wei, M.C., and Korsmeyer, S.J., 1998, Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis, EMBO J. 17:3878–3885.
Guarini, L., Temponi, M., Edwalds, G.M., Vita, J.R., Fisher, P.B., and Ferrone, S., 1989, In vitro differentiation and antigenic changes in human melanoma cell lines. Cancer Immunol. Immunother. 30:262–268.
Guarini, L., Graham, G.M., Jiang, H.. Ferrone, S., Zucker, S., and Fisher, P.B., 1992, Modulation of the antigenic phenotype of human melanoma cells by differentiation-inducing and growth-suppressing agents, Pigment Ceil Res. Suppl. 2:123–131.
Han, Z., Malik, N., Carter, T., Reeves, W.H., Wyche, J.H., and Hendrickson, E.A., 1996, DNA-dependent protein kinase is a target for a CPP32-like apoptotic protease, J. Biol. Chem. 271:25035–25040.
Harper, J.W., Adami, G.R., Wei, N., Keyomarsi, K., and Elledge, S.J.. 1993, The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805–816.
Hartwell, L.H., and Kastan, M.B., 1994, Cell cycle control of cancer, Science 266:1821–1828.
Heise, C., Sampson-Johannes, A., Williams, A., McCormick, F., von Hoff, D.D., and Kirn, D.H., 1997, ONYX015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents. Nature Med. 3:639–645.
Herlyn, M., 1990, Human melanoma: development and progression, Cancer Metastasis Rev. 9:101–112.
Huang, F., Adelman, J., Jiang, H., Goldstein, N.I., and Fisher, P.B., 1998, Differentiation induction subtraction hybridization (DISH): an approach for defining the spectrum of genes differentially expressed during induction of irreversible growth arrest and terminal differentiation in human melanoma cells, Oncogene in press.
Huang, D.C., Cory, S., and Strasser, A., 1997, Bcl-2, Bel-XL and adenovirus protein E1B19kD are functionally equivalent in their ability to inhibit cell death, Oncogene 14:405–414.
Hwang, R.F., Gordon, E.M., Anderson, W.F., and Parekh, D., 1998, Gene therapy for primary and metastatic pancreatic cancer with intraperitoneal retroviral vector bearing the wild-type p53 gene, Surgery 124:143–150.
Ito, T., Deng, X.M., Carr, B., and May, W.S., 1997, Bcl-2 phosphorylation required for anti-apoptosis function, J. Biol. Chem. 272:11671–11673.
Jiang, H., and Fisher, P.B., 1993, Use of a sensitive and efficient subtraction hybridization protocol for the identification of genes differentially regulated during the induction of differentiation in human melanoma cells. Mol. Cell Different. 2:221–239.
Jiang, H., Su, Z.-Z., Boyd, J., and Fisher, P.B., 1993a, Gene expression changes associated with reversible growth suppression and the induction of terminal differentiation in human melanoma cells, Mol. Cell Different. 1:41–66.
Jiang, H., Waxman, S., and Fisher, P.B., 1993b, Regulation of c-fos, c-jun and jun-B expression in human melanoma cells induced to terminally differentiate, Mol. Cell Different. 1:197–214.
Jiang, H., Lin, J., and Fisher, P.B., 1994, A molecular definition of terminal differentiation in human melanoma cells, Mol. Cell Different. 2:221–239.
Jiang, H., Lin, J.J., Su, Z.-Z., Goldstein, N.I., and Fisher, P.B., 1995a, Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression, Oncogene 11:2477–2486.
Jiang, H., Lin, J., Su, Z.-Z., Herlyn, M., Kerbel. R.S., Weissman, B.E., Welch, D.R., and Fisher, P.B., 1995b, The melanoma differentiation-associated gene mda-6, which encodes the cyclin-dependent kinase inhibitor p21, is differentially expressed during growth, differentiation and progression in human melanoma cells, Oncogene 10:1855–1864.
Jiang, H., Lin, J., Young, S.-M., Goldstein, N.I.. Waxman, S., Davila, V, Chellappan, S.P., and Fisher. P.B., 1995c, Cell cycle gene expression and E2F transcription factor complexes in human melanoma cells induced to terminally differentiate, Oncogene 11:1179–1189.
Jiang, H., Su, Z.-Z., Lin, J.J., Goldstein, N.I., Young, C.S.H., and Fisher, P.B., 1996, The melanoma differentiation associated gene mda-7 suppresses cancer cell growth, Proc. Natl. Acad. Sci. USA 93:9160–9165.
Jimenez, J.J., and Yunis, A.A., 1987, Tumor cell rejectionthrough terminal cell differentiation, Science 238:1278–1280.
Kang, D.-C., Motwani, M., and Fisher, P.B., 1998. Role of the transcription factor AP1 in melanoma differentiation (review), Intl. J. Oncology, in press.
Kerbel, R.S., 1990, Growth dominance and the metastatic cancer cell: cellular and molecular aspects, Adv. Cancer Res. 55:87–132.
Kieff, E., 1998, Current perspectives on the molecular pathogenesis of virus-induced cancers in human immunodeficiency virus infection and acquired immunodeficiency syndrome. [Review], J. Nat. Cancer Inst. Monographs 23:7–14.
Kobayashi, H., Man, S., MacDougall, J.R., Graham, C.H., Lu, C., and Kerbel, R.S., 1994, Variant sublines of early-stage human melanomas selected for tumorigenicity in nude mice express a multicytokineresistant phenotype, Amer. J. Pathol. 144:776–786.
Kong, H.L., and Crystal, R.G., 1998, Gene therapy strategies for tumor antiangiogenesis, J. Natl. Cancer Inst. 90:270–271.
Knudson, A.G., 1993, Antioncogenes and human cancer, Proc. Natl. Acad. Sci. USA 90:10914–10921.
Kroemer, G., 1997, The proto-oncogene Bcl-2 and its role in regulating apoptosis, Nature Med. 6:614–620.
Levine, A.J., 1993, The tumor suppressor genes, Annu. Rev. Biochem. 62:623–651.
Li, P., Deepak, K, Budihardjo, I., Srinivasula, S.M., Ahmad, M., Alnemri, E.S., and Wang X., 1997a, Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic cascade, Cell 91:479–489.
Li, F, Srinivasan, A., Wang, Y, Armstrong, R.C., Tomaselli, K.J., and Fritz, L.C., 1997b, Cell-specific induction of apoptosis by microinjection of cytochrome c-Bcl-KL has activity independent of cytochrome c release, J. Biol. Chem. 272:30299–30305.
Lin, J.J., Jiang, H., and Fisher, P.B., 1996, Characterization of a novel melanoma differentiation associated gene, mda-9, that is down-regulated during terminal cell differentiation, Mol. Cell Different. 4:317–333.
Lin, J.J., Jiang, H., and Fisher, P.B., 1998, Melanoma differentiation associated gene-9, mda-9, is a human gamma interferon responsive gene, Gene 207:105–110.
Lu, C., and Kerbel, R.S., 1994, Cytokines, growth factors and the loss of negative growth controls in the progression of human cutaneous malignant melanoma, Curr. Opin. Oncol. 6:213–234.
Marchetti, P., Castedo, M., Susin, S.A., Zamzami, N., Hirsch, T., Macho, A., Haeffner, A., Hirsch, F, Geuskens, M., and Kroemer, G., 1996, Mitochondrial permeability transition is the central coordinating event of apoptosis. J. Exptl. Med. 184:1153–1160.
Melber, K., Zhu, G., and Diamond, L., 1989, SV40-transformed human melanocyte sensitivity to growth inhibition by the phorbol ester 12-0-tetradecanoylphorbol-13-acetate, Cancer Res. 49:3650–3655.
Moolten, F.L., and Wells, J.M., 1990, Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors. PJ. Natl. Cancer Inst. 82:297–300.
Mosmann, T.R., 1994, Properties and functions of interleukin-10. [Review], Advan. Immunol. 56:1–26.
Noda, A., Ning, Y, Venable, S.F., Pereira-Smith, O.M., and Smith, J.R., 1994, Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen, Exptl. Cell Res. 211:90–98.
O’Neill, M.J., and Artzt, K., 1995, Identification of a germ-cell-specific transcriptional repressor in the promoter of Tctex-1. Development 12:561–568.
Ottavi, Z.N., Miliman, C.L., and Korsmeyer, S.J., 1993, Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death, Cell 74:609–619.
Prabhu, N.S., Somasundaram, K., Satyamoorthy, K., Herlyn, M., and El-Deiry, W.S., 1998, p73beta, unlike p53, suppresses growth and induces apoptosis of human papillomavirus E6-expressing cancer cells, Intl. J. Oncology 13:5–9.
Reed, J.C., 1995, Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance, Curr. Opin. Oncol. 7:541–546.
Reed, J.C., 1997, Bcl-2 family proteins: regulators of apoptosis and chemoresistance in hematologic malignancies, Seminars Hematol. 34(4 Suppl 5):9–19.
Roberts, T., Vrana, J.A., Grant S., and Fisher, P.B., 1998, Differentiation therapy of cancer: basic science and clinical applications, Pharmacol. Therapeut. in press.
Rocco, J.W., Li, D., Liggett, W.H., Jr., Duan, L., Saunders, J.K., Jr., Sidransky, D., and O’Malley, B.W., Jr., 1998, p16INK4A adenovirus-mediated gene therapy for human head and neck squamous cell cancer, Clinical Cancer Res. 4:1697–1704.
Rodriguez, R., Schuur, E.R., Lim, H.Y, Henderson, G.A., Simons, J.W., and Henderson, D.R., 1997, Prostate attenuated replication competent adenovirus (ARCA) CN706: a selective cytotoxic for prostate-specific antigen-positive prostate cancer cells. Cancer Res. 57:2559–2563.
Rosenberg, S.A., 1992, Gene therapy for cancer. J. Amer. Med. Assoc. 268:2416–2419.
Roth, J.A., and Cristiano, R.J., 1997, Gene therapy for cancer: what have we done and where are we going?, J. Natl. Cancer Inst. 89:21–39.
Roth, J.A., Swisher, S.G., Merritt, J.A., Lawrence, D.D., Kemp, B.L., Carrasco, C.H., El-Naggar, A.K., Fossella, F.V., Glisson, B.S., Hong, W.K., Khurl, F.R., Kurie, J.M., Nesbitt, J.C., Pisters, K., Putnam, J.B., Schrump, D.S., Shin, D.M., and Walsh, G.L., 1998, Gene therapy for non-small cell lung cancer: a preliminary report of a phase I trial of adenoviral p53 gene replacement, Sem. in Oncology 25:33–37.
Roux, A.F., Rommens, J., McDowell, C., Anson-Cartwright, L., Bell, S., Schappert, K., Fishman, G.A., and Musarella, M., 1994, Identification of a gene from Xp21 with similarity to the tctex-1 gene of the murine t complex. Hum. Mol. Genet. 3:257–263.
Sachs L., 1978. Control of normal cell differentiation and the phenotypic reversion of malignancy in myeloid cells, Nature 274:535–539.
Sandig, V, Brand, K., Herwig, S., Lukas, J., Bartek, J., and Strauss. M., 1997, Adenovirally transferred p16INK4/CDKN2 and p53 genes cooperate to induce apoptotic tumor cell death, Nature Med. 3:313–319.
Schendel, S.L., Montal, M., and Reed, J.C., 1998, Bcl-2 family proteins as ion-channels. Cell Growth & Different. 5:372–380.
Smythe, W.R., Hwang, H.C., Amin, K.M., Eck, S.L., Davidson, B.L., Wilson, J.M., Kaiser, L.R., and Albelda, S.M., 1994, Use of recombinant adenovirus to transfer the herpes simplex virus thymidine kinase (HSV-TK.) gene to thoracic neoplasms: an effective in vitro drug sensitization system. Cancer Res. 54:2055–2059.
Soos, T.J., Park, M., Kiyokawa, H., and Koff, A., 1998, Regulation of the cell cycle by CDK inhibitors. Results and problems. [Review], Cell Differ. 22:111–131.
Smith, A.E., 1995, Viral vectors in gene therapy, Annu. Rev. Microbiol. 49:807–838.
Su, Z.-Z., Shi, Y, and Fisher, P.B., 1997, Subtraction hybridization identifies a transformation progression-associated gene PEG-3 with sequence homology to a growth arrest and DNA damage inducible gene. Proc. Natl. Acad. Sci. USA 94:9125–9130.
Su, Z.-Z., Goldstein, N.I., and Fisher, P.B., 1998a, Antisense inhibition of the PTI-1 oncogene reverses cancer phenotypes, Proc. Natl. Acad. Sci. USA 95:1764–1769.
Su, Z.-Z., Madireddi, M.T., Lin, J.J., Young, C.S.H., Kitada, S., Reed, J.C., Goldstein, N.I., and Fisher, P.B., 1998b, The cancer growth suppressor gene mda-7 selectively induces apoptosis in human cancer cells and inhibits tumor growth in nude mice, Proc. Natl. Acad. Sci. USA in press.
Su, Z.-Z., Madireddi, M.T., Young, C.S.H., Jiang, H., Goldstein, N.I., and Fisher, P.B., 1998c, Melanoma differentiation associated gene-7 (Mda-7): a ubiquitous cancer growth suppressor gene, in Cancer Gene Therapy, (N. Habib, ed.), IBC Series, in press.
Takeda, S., Nakao, A., Miyoshi, K., and Takagi, H., 1998, Gene therapy for pancreatic cancer, Semi. Surg. Oncol. 15:57–61.
Vogelstein, B., and Kinzler, K. W, 1991, The multistep nature of cancer, Trends Genet. 9:138–141.
Waxman, S., (ed.), 1995, Differentiation Therapy, Vol. 10, pp. 1–531, Ares Serono Symposia, Rome, Italy.
White, E., 1996, Life, death, and the pursuit of apoptosis, Genes & Dev. 10:1–15.
Wilson, M.R., 1998, Apoptosis: unmasking the executioner, Cell Death & Different. 5:646–652.
Xu, H.J., Zhou, Y, Seigne, J., Perng, G.S., Mixon, M., Zhang, C., Li, J., Benedict, W.F., and Hu, S.X., 1996, Enhanced tumor suppressor gene therapy via replication-deficient adenovirus vectors expressing an N-terminal truncated retinoblastoma protein, Cancer Res. 56:2245–2249.
Yin, X.M., Ottavi, Z.N., and Korsmeyer, S.J., 1994, BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax, Nature 26:272–273.
Zhang, Y, Mukhopadhyay, T., Donehower, L.A., Georges, R.N., and Roth, J.A., 1993, Retroviral vector-mediated transduction of K-ras antisense RNA into human lung cancer cells inhibits expression of the malignant phenotype, Human Gene Therapy 4:451–460.
Zuo, H., Henzel, W.J., Liu, X.S., Lutschg, A., and Wang, X.D., 1997, Apaf-1, a human protein homologous to C. elegans Ced-4, participates in cytochrome c-dependent activation of caspase-3, Cell 91:405–413.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Kluwer Academic Publishers
About this chapter
Cite this chapter
Madireddi, M.T., Su, ZZ., Young, C.S.H., Goldstein, N.I., Fisher, P.B. (2002). Mda-7, A Novel Melanoma Differentiation Associated Gene with Promise for Cancer Gene Therapy. In: Habib, N.A. (eds) Cancer Gene Therapy. Advances in Experimental Medicine and Biology, vol 465. Springer, New York, NY. https://doi.org/10.1007/0-306-46817-4_22
Download citation
DOI: https://doi.org/10.1007/0-306-46817-4_22
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-306-46191-0
Online ISBN: 978-0-306-46817-9
eBook Packages: Springer Book Archive